NEW YORK (GenomeWeb News) — Affymetrix today said second-quarter revenue rose 10 percent, R&D costs dropped 10 percent, and a net loss swung to a small profit.
 
Total revenue for the three months ended June 30 rose to $88.3 million from $80.1 million year over year.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.